Prem S. Sarin

7.1k citations

87 papers · 5.6k indexed · 2 hit papers · h-index 33

Impact in

Virology top 0.5%
- HIV Research and Treatment
Agronomy and Crop Science top 0.2%
- Animal Disease Management and Epidemiology

Papers in

Virology 25
- HIV Research and Treatment 25
Agronomy and Crop Science 29
- Animal Disease Management and Epidemiology 29

Co-authors: Paul C. Zamecnik Robert C. Gallo John Goodchild Sudhir Agrawal Arthur Thornton V. S. Kalyanaraman M.P. Civeira T Ikeuchi
Journals: Proceedings of the National Academy of Sciences (11 papers)Biochemical and Biophysical Research Communications (6 papers)International Journal of Cancer (4 papers)Cancer (3 papers)Science (3 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Prem S. Sarin

87 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS) 1983 · 791 citations

Peers

Countries citing papers authored by Prem S. Sarin

Since Specialization

Citations

This map shows the geographic impact of Prem S. Sarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prem S. Sarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prem S. Sarin more than expected).

Fields of papers citing papers by Prem S. Sarin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prem S. Sarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prem S. Sarin. The network helps show where Prem S. Sarin may publish in the future.

Co-authors

The 25 scholars most cited alongside Prem S. Sarin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Prem S. Sarin Line = papers co-authored together Prem S. Sarin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine International Journal of Immunopharmacology ·В. М. Писарев, Prahlad Parajuli, R. Lee Mosley, Irla Micaele Moreira Linhares, Linda Kelsey, Prem S. Sarin, Daniel H. Zimmerman, Hengki Heriyadi, James E. Talmadge	2000	18
2	Marriage, monogamy and HIV: a profile of HIV-infected women in south India International Journal of STD & AIDS ·Sara J. Newmann, Prem S. Sarin, N Kumarasamy, А. А. Градюшко, Gerardo Ávalos Cacho, Purnima Madhivanan, Timothy Flanigan, Susan Cu‐Uvin, Stephen T. McGarvey, Kenneth H. Mayer, S Solomon	2000	169
3	Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID mice Vaccine ·Prem S. Sarin, James E. Talmadge, Peter N.R. Heseltine, Judit Popovics, Howard E. Gendelman, Ryan G. Coleman, ROBERT L. SCHELONKA, Suzanne K. Beckner, Marcelo Alexandrino, Jeffrey Kahn	1999	8
4	Treatment of AIDS with Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle Immunopharmacology and Immunotoxicology ·Prem S. Sarin, Allan L. Goldstein	1995	7
5	Cytotoxic and humoral immune responses to HIV-1 p17 synthetic peptide HGP-30 in human volunteers Prem S. Sarin, I. Miura, Paul H. Naylor, Jeffrey Kahn, Peter N.R. Heseltine, Brian Gazzard, M Youle, Nur Hafidz, Allan L. Goldstein	1994	1
6	A Phase I Study of HGP-30, a 30 Amino Acid Subunit of the Human Immunodeficiency Virus (HIV) p17 Synthetic Peptide Analogue Sub-unit Vaccine in Seronegative Subjects AIDS Research and Human Retroviruses ·Benjamin N Bernardo, Yongdong Shi, S De Luca, Judit Popovics, Richard Stryker, Paul A. Volberding, Paul H. Naylor, Principe di Teano, Prem S. Sarin, Jiří PFLANZER, R. Yu. Bogomazov, Peter N.R. Heseltine	1992	18
7	Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH International Journal of Immunopharmacology ·Paul H. Naylor, Marcelo B. Sztein, O.Y. Parkhаmchuk, Scott H. Maurer, Daniel A. Holterman, Janet E. Kirkley, COSTAS ABATZIS, Bernard C. Zook, Susana y Calloway, Clarence J. Gibbs, Daniel Zagury, Ammar Achour, Carol O’Toole, Brian Gazzard, Mike Youle, 川辺允志, Prem S. Sarin, Allan L. Goldstein	1991	24
8	Immune response and epitope mapping of a candidate hiv‐1 p17 vaccine hgp30 Journal of Clinical Laboratory Analysis ·Charles A. Boucher, W Krone, Jaap Goudsmit, Rob H. Meloen, Paul H. Naylor, Allan L. Goldstein, Daisy Sun, Prem S. Sarin	1990	23
9	Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: Anti-HIV activity, physical properties, and interaction with plasma proteins Biochemical and Biophysical Research Communications ·Joseph M. Steim, Catherine Neto, Prem S. Sarin, Daisy Sun, Raj K. Sehgal, Joseph G. Turcotte	1990	31
10	HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proceedings of the National Academy of Sciences ·Adnane Achour, O Picard, Daniel Zagury, Prem S. Sarin, Robert C. Gallo, Paul H. Naylor, Allan L. Goldstein	1990	46
11	Inhibition of HIV replication by liposomal encapsulated amphotericin B Antiviral Research ·Anjali Nair, Di Sun, P. Krause, Edlaine Faria de Moura Vilela, Otto J. Plescia, C. P. Schaffner, Gabriel Lopez‐Berestein, Prem S. Sarin	1989	25
12	Inhibition of Expression of Natural UAG Suppressor Glutamine tRNA in HIV-Infected Human H9 Cells In Vitro by Avarol AIDS Research and Human Retroviruses ·Wernér E.G. Müller, Heinz C. Schröder, Betül Yüce, Prem S. Sarin, Samira S. Bekheit, Karl‐H. Meyer zum Büschenfelde, Yoshiyuki Kuchino, Susumu Nishimura	1988	14
13	The role of HTLV-I in tropical spastic paraparesis in jamaica Annals of Neurology ·Pamela Rodgers‐Johnson, Owen Morgan, Carlos A. Mora, Prem S. Sarin, Mauro Ceroni, Pedro Piccardo, Ralph M. Garruto, Clarence J. Gibbs, D. Carleton Gajdusek	1988	48
14	Neutralization of HTLV-III/LAV Replication by Antiserum to Thymosin α ₁ Science ·Prem S. Sarin, Daisy Sun, Arthur Thornton, Paul H. Naylor, Allan L. Goldstein	1986	122
15	Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes. Journal of Clinical Investigation ·Rodríguez Escuredo, Donald R. Bertolini, Prem S. Sarin, Susan T. Weintraub, G R Mundy, James F. Dunn	1986	71
16	Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. Journal of Clinical Investigation ·T. A. Waldmann, Warner C. Greene, Prem S. Sarin, Carl Saxinger, Douglas W. Blayney, W. A. Blattner, C K Goldman, Kathleen F. Bongiovanni, Susan O. Sharrow, J M Depper	1984	191
17	High incidence of human type-C retrovirus (HTLV) in family members of a HTLV-positive Japanese T-cell leukemia patient. Proceedings of the National Academy of Sciences ·Prem S. Sarin, Tadao Aoki, Akira Shibata, Yoshihisa Ohnishi, Yoko Aoyagi, Hideo Miyakoshi, Iwao Emura, V. S. Kalyanaraman, Marjorie Robert-Guroff, M Popovic, M. G. Sarngadharan, P C Nowell, Robert C. Gallo	1983	53
18	Inhibitors of DNA and RNA polymerases Pergamon Press eBooks ·Prem S. Sarin, Robert C. Gallo	1980	20
19	Purification and characterization of baboon endogenous virus DNA polymerase Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis ·Prem S. Sarin, Valerie Jacobs Kremer, Robert C. Gallo	1977	11
20	The evidence for involvement of type C RNA tumor viruses in human acute leukemia Cancer ·Robert C. Gallo, Robert E. Gallagher, M. G. Sarngadharan, Prem S. Sarin, Marvin S. Reitz, N. R. Miller, David Gillespie	1974	15

About Prem S. Sarin

Prem S. Sarin is a scholar working on Virology, Agronomy and Crop Science, Immunology, Infectious Diseases and Ecology, Evolution, Behavior and Systematics, having authored 87 papers that have together received 5.6k indexed citations. Recurring topics across this work include T-cell and Retrovirus Studies (32 papers), Animal Disease Management and Epidemiology (29 papers), HIV Research and Treatment (25 papers), Vector-Borne Animal Diseases (23 papers), HIV/AIDS drug development and treatment (20 papers), Immune Cell Function and Interaction (9 papers), RNA and protein synthesis mechanisms (8 papers) and DNA and Nucleic Acid Chemistry (7 papers). The work is most often cited by research in Virology (1.3k citations), Agronomy and Crop Science (1.2k citations), Immunology (2.3k citations), Infectious Diseases (1.1k citations) and Ecology, Evolution, Behavior and Systematics (1.1k citations). Prem S. Sarin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Paul C. Zamecnik, Robert C. Gallo, John Goodchild, Sudhir Agrawal, Arthur Thornton, V. S. Kalyanaraman, M.P. Civeira, T Ikeuchi, Marjorie Robert-Guroff and Mikuláš Popovič. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications, International Journal of Cancer, Cancer and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact